Copper-Cleaning dialysis device tested for Wilson's disease – but trial stopped early

NCT ID NCT05917327

First seen Jan 05, 2026 · Last updated May 02, 2026 · Updated 13 times

Summary

This study tested a special dialysis machine (MEX-CD1) designed to remove extra copper from the blood of people with Wilson's disease, a genetic condition that causes copper buildup. The trial planned to enroll patients aged 10 to 80, but was terminated after only one participant. The goal was to see if the device safely and effectively lowers copper levels.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATOLENTICULAR DEGENERATION; WILSON are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Hospital Clinic Barcelona, Liver ICU

    Barcelona, Catalonia, 08036, Spain

  • Hospital Universitario Vall d'Hebron, Unitat de Trasplantament Hepàtic Pediàtric

    Barcelona, Catalonia, 08035, Spain

  • Hôpital Croix Rousse, Service d'hépatologie et gastroentérologie

    Lyon, Auvergne-Rhône-Alpes, 69317, France

  • Hôpital Femme Mère Enfant, Service des urgences et la réanimation pédiatriques

    Bron, Auvergne-Rhône-Alpes, 69500, France

Conditions

Explore the condition pages connected to this study.